Patents Assigned to MAXPLANCK-GESELLSCHAFT ZUR FÕRDERUNG DER WISSENSCH
  • Publication number: 20100103413
    Abstract: A spectroscopic analysis of a sample includes arranging the sample in a resonator cavity for transmitting cavity mode frequencies with a cavity mode frequency spacing, coupling pulsed source light into the resonator cavity, with the source light including source comb frequencies with a source frequency spacing, coupling pulsed transmitted light out of the resonator cavity, and spectrally resolved detecting the transmitted light with a detector device. The cavity mode frequency spacing and the source frequency spacing are detuned relative to each other, so that the transmitted light includes transmitted comb frequencies with a spacing larger than the source frequency spacing. The detecting feature includes collecting spectral distributions of the transmitted light in dependence on relative positions of the cavity mode frequencies and the source comb frequencies.
    Type: Application
    Filed: December 19, 2007
    Publication date: April 29, 2010
    Applicant: MAXPLANCK-GESELLSCHAFT ZUR FÕRDERUNG DER WISSENSCH
    Inventors: Christoph Gohle, Albert Schliesser, Theodor W. Haensch
  • Publication number: 20090028851
    Abstract: The present invention relates to a particularly advantageous antibody, antibody fragment or derivative thereof, which specifically binds to/interacts with at least one epitope of the extracellular or intracellular domain or the mammalian EAG1 ion channel and to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to methods for the preparation of said antibody, antibody fragments or derivatives thereof and to pharmaceutical compositions comprising the same. Furthermore, the use of said antibody, antibody fragment or derivative thereof and also diagnostic compositions comprising said components are disclosed in the specification. The invention also relates to a method of assessing for the presence of EAG1 expressing cells and for a method of blocking EAG1 function in said cells. The invention further relates to a method of treating diseases with the help or said antibody or antibody fragment or derivative thereof.
    Type: Application
    Filed: October 4, 2005
    Publication date: January 29, 2009
    Applicants: MAXPLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCH, U3 PHARMA AG
    Inventors: Walter Stuhmer, Hendrik Knotgen, David Gomez-Varela, Luis A. Pardo, Mike Rothe, Esther Zwick-Wallasch, Kerstin Dehne
  • Publication number: 20080155713
    Abstract: The present invention relates to the field of genes isolated from Arabidopsis that code for enzymes that are involved in -oxidation of very long chain fatty acids, particularly, in conversion of ?-hydroxy fatty acid to fatty aldehyde. The invention also includes methods of producing transgenic plants with an altered fatty acid composition. Furthermore, the present invention relates to assays making use of these enzymes as herbicide targets to identify inhibitors of said enzymes, thereby providing herbicidally active compounds.
    Type: Application
    Filed: August 9, 2005
    Publication date: June 26, 2008
    Applicants: BAYER CROPSCIENCE GMBH, MAXPLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCH
    Inventors: Alexander Yephremov, Heinz Saedler, Klaus-Gunther TietJen, Sandra Trenkamp, Lukas Schreiber
  • Publication number: 20070224264
    Abstract: The present invention relates to a method for remote control release of encapsulated substances by external forces such as ultrasound or light.
    Type: Application
    Filed: May 4, 2005
    Publication date: September 27, 2007
    Applicant: MAXPLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCH
    Inventors: Alexei Antipov, Arif Mamedov, Gleb Sukhorukov, Helmuth Mohwald, Nicholas Kotov, Andre Skirtach